BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 31394192)

  • 21. Effect of miR-21 on Apoptosis in Lung Cancer Cell Through Inhibiting the PI3K/ Akt/NF-κB Signaling Pathway in Vitro and in Vivo.
    Zhou B; Wang D; Sun G; Mei F; Cui Y; Xu H
    Cell Physiol Biochem; 2018; 46(3):999-1008. PubMed ID: 29669316
    [TBL] [Abstract][Full Text] [Related]  

  • 22. miR-33-5p knockdown attenuates abdominal aortic aneurysm progression via promoting target adenosine triphosphate-binding cassette transporter A1 expression and activating the PI3K/Akt signaling pathway.
    Zhao L; Huang J; Zhu Y; Han S; Qing K; Wang J; Feng Y
    Perfusion; 2020 Jan; 35(1):57-65. PubMed ID: 31170866
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Up-regulation of miR-200b in biliary atresia patients accelerates proliferation and migration of hepatic stallate cells by activating PI3K/Akt signaling.
    Xiao Y; Wang J; Chen Y; Zhou K; Wen J; Wang Y; Zhou Y; Pan W; Cai W
    Cell Signal; 2014 May; 26(5):925-32. PubMed ID: 24412919
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MiR-592 Promotes Gastric Cancer Proliferation, Migration, and Invasion Through the PI3K/AKT and MAPK/ERK Signaling Pathways by Targeting Spry2.
    He Y; Ge Y; Jiang M; Zhou J; Luo D; Fan H; Shi L; Lin L; Yang L
    Cell Physiol Biochem; 2018; 47(4):1465-1481. PubMed ID: 29949784
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long Noncoding RNA PVT1 Silencing Prevents the Development of Uveal Melanoma by Impairing MicroRNA-17-3p-Dependent MDM2 Upregulation.
    Wu S; Chen H; Han N; Zhang C; Yan H
    Invest Ophthalmol Vis Sci; 2019 Nov; 60(14):4904-4914. PubMed ID: 31770435
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Highly-expressed micoRNA-21 in adipose derived stem cell exosomes can enhance the migration and proliferation of the HaCaT cells by increasing the MMP-9 expression through the PI3K/AKT pathway.
    Yang C; Luo L; Bai X; Shen K; Liu K; Wang J; Hu D
    Arch Biochem Biophys; 2020 Mar; 681():108259. PubMed ID: 31926164
    [TBL] [Abstract][Full Text] [Related]  

  • 27. miR-489 inhibits proliferation, cell cycle progression and induces apoptosis of glioma cells via targeting SPIN1-mediated PI3K/AKT pathway.
    Li Y; Ma X; Wang Y; Li G
    Biomed Pharmacother; 2017 Sep; 93():435-443. PubMed ID: 28666210
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High-mobility group A1 proteins enhance the expression of the oncogenic miR-222 in lung cancer cells.
    Zhang Y; Ma T; Yang S; Xia M; Xu J; An H; Yang Y; Li S
    Mol Cell Biochem; 2011 Nov; 357(1-2):363-71. PubMed ID: 21656127
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroRNA-24 attenuates vascular remodeling in diabetic rats through PI3K/Akt signaling pathway.
    Cai W; Zhang J; Yang J; Fan Z; Liu X; Gao W; Zeng P; Xiong M; Ma C; Yang J
    Nutr Metab Cardiovasc Dis; 2019 Jun; 29(6):621-632. PubMed ID: 31005375
    [TBL] [Abstract][Full Text] [Related]  

  • 30. miR-188-5p regulates proliferation and invasion via PI3K/Akt/MMP-2/9 signaling in keloids.
    Zhu W; Wu X; Yang B; Yao X; Cui X; Xu P; Chen X
    Acta Biochim Biophys Sin (Shanghai); 2019 Feb; 51(2):185-196. PubMed ID: 30668826
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MiR-142-3p functions as a potential tumor suppressor in human osteosarcoma by targeting HMGA1.
    Xu G; Wang J; Jia Y; Shen F; Han W; Kang Y
    Cell Physiol Biochem; 2014; 33(5):1329-39. PubMed ID: 24803022
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High mobility group AT-hook 1 (HMGA1) is an independent prognostic factor and novel therapeutic target in pancreatic adenocarcinoma.
    Liau SS; Rocha F; Matros E; Redston M; Whang E
    Cancer; 2008 Jul; 113(2):302-14. PubMed ID: 18473350
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MicroRNA-34a inhibits uveal melanoma cell proliferation and migration through downregulation of c-Met.
    Yan D; Zhou X; Chen X; Hu DN; Dong XD; Wang J; Lu F; Tu L; Qu J
    Invest Ophthalmol Vis Sci; 2009 Apr; 50(4):1559-65. PubMed ID: 19029026
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long noncoding RNA-JPX predicts the poor prognosis of ovarian cancer patients and promotes tumor cell proliferation, invasion and migration by the PI3K/Akt/mTOR signaling pathway.
    Li J; Feng L; Tian C; Tang YL; Tang Y; Hu FQ
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8135-8144. PubMed ID: 30556851
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The PI3K/Akt and mTOR/P70S6K signaling pathways in human uveal melanoma cells: interaction with B-Raf/ERK.
    Babchia N; Calipel A; Mouriaux F; Faussat AM; Mascarelli F
    Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):421-9. PubMed ID: 19661225
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
    Lu C; Shan Z; Hong J; Yang L
    Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MiR-21 attenuates apoptosis-triggered by amyloid-β via modulating PDCD4/ PI3K/AKT/GSK-3β pathway in SH-SY5Y cells.
    Feng MG; Liu CF; Chen L; Feng WB; Liu M; Hai H; Lu JM
    Biomed Pharmacother; 2018 May; 101():1003-1007. PubMed ID: 29635890
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MicroRNA 145 may play an important role in uveal melanoma cell growth by potentially targeting insulin receptor substrate-1.
    Li Y; Huang Q; Shi X; Jin X; Shen L; Xu X; Wei W
    Chin Med J (Engl); 2014; 127(8):1410-6. PubMed ID: 24762580
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MicroRNA-93 activates c-Met/PI3K/Akt pathway activity in hepatocellular carcinoma by directly inhibiting PTEN and CDKN1A.
    Ohta K; Hoshino H; Wang J; Ono S; Iida Y; Hata K; Huang SK; Colquhoun S; Hoon DS
    Oncotarget; 2015 Feb; 6(5):3211-24. PubMed ID: 25633810
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNA-146b promotes PI3K/AKT pathway hyperactivation and thyroid cancer progression by targeting PTEN.
    Ramírez-Moya J; Wert-Lamas L; Santisteban P
    Oncogene; 2018 Jun; 37(25):3369-3383. PubMed ID: 29353884
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.